Fast Company June 14, 2020
Ruth Reader

Machine learning can speed up the creation of new drugs and unlock the mysteries of major diseases, says Insitro CEO Daphne Koller.

Daphne Koller is best known as the cofounder of Coursera, the open database for online learning that launched in 2012. But before her work on Coursera, she was doing something much different. In 2000, Koller started working on applying machine learning to biomedical datasets to understand gene activity across cancer types. She put that work on hold to nurture Coursera, which took many more years than she initially thought it would. She didn’t return to biology until 2016 when she joined Alphabet’s life science research and development arm Calico.

Two years later, Koller started...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Interview / Q&A, Pharma, Pharma / Biotech, Technology, Trends
The Digital Dentist: Exploring the Latest Technological Advances in Dental Care
Venture Capitalist David Sacks Debuts Work-Oriented AI Chat Platform Glue
AI database to bolster research for GLP1-RAs as precision medicines
These are the 2024 CNBC Disruptor 50 companies: See the full list of startups riding the AI wave
HHS to award grants for AI, behavioral health projects

Share This Article